Christine C. Cheng

2.9k citations

20 papers · 2.0k indexed · 1 hit paper · h-index 16

Co-authors: Alexei Kharitonenkov Andrew C. Adams Tamer Coşkun Ruth E. Gimeno Ricardo J. Samms Yongde Luo Chaofeng Yang Christine M. Kusminski
Topics: Fibroblast Growth Factor Research (16 papers)Kruppel-like factors research (12 papers)Epigenetics and DNA Methylation (11 papers)
Cited by: Molecular Biology Physiology Endocrine and Autonomic Systems
Journals: Journal of Clinical Investigation PLoS ONE The Journal of Clinical Endocrinology & Metabolism
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Christine C. Cheng

20 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice

2013 455 citations William L. Holland, Andrew C. Adams et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Christine C. Cheng

Since Specialization

Citations

This map shows the geographic impact of Christine C. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine C. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine C. Cheng more than expected).

Fields of papers citing papers by Christine C. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine C. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine C. Cheng. The network helps show where Christine C. Cheng may publish in the future.

Co-authorship network of co-authors of Christine C. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Christine C. Cheng. A scholar is included among the top collaborators of Christine C. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine C. Cheng. Christine C. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes 2022 ·American Journal of Physiology-Endocrinology and Metabolism ·Ricardo J. Samms,Christine C. Cheng,Marcel Fourcaudot,Sami Heikkinen,Ahmed Khattab,John M. Adams,Eugênio Cersósimo,Curtis Triplitt,(unknown),Kostas Tsintzas,Andrew C. Adams,Muhammad Abdul‐Ghani,Ralph A. DeFronzo,Luke Norton	7
2	Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity 2019 ·International Journal of Obesity ·Marleen A. van Baak,Roel Vink,Nadia Roumans,Christine C. Cheng,Andrew C. Adams,Edwin C.M. Mariman	10
3	Eccentric exercise increases circulating fibroblast activation protein α but not bioactive fibroblast growth factor 21 in healthy humans 2018 ·Experimental Physiology ·(unknown),Jo E. Lewis,Ricardo J. Samms,Francis J. P. Ebling,Christine C. Cheng,Andrew C. Adams,Joanne Mallinson,Scott Cooper,(unknown),Reza Ghasemi,Francis B. Stephens,Kostas Tsintzas	15
4	Abnormal trading behavior of specific types of shareholders before US firm bankruptcy and its implications for firm bankruptcy prediction 2018 ·Journal of Business Finance &amp Accounting ·Christine C. Cheng,Stewart Jones,William J. Moser	15
5	FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans 2017 ·The Journal of Clinical Endocrinology & Metabolism ·Ricardo J. Samms,Jo E. Lewis,Luke Norton,Francis B. Stephens,Christopher Gaffney,(unknown),Dennis P. Smith,Christine C. Cheng,James W. Perfield,Andrew C. Adams,Francis J. P. Ebling,Kostas Tsintzas	54
6	Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity 2016 ·Endocrinology ·Ricardo J. Samms,Christine C. Cheng,Alexei Kharitonenkov,Ruth E. Gimeno,Andrew C. Adams	58
7	Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1 2015 ·Cell Reports ·Ricardo J. Samms,Dennis P. Smith,Christine C. Cheng,(unknown),James W. Perfield,Alexei Kharitonenkov,Ruth E. Gimeno,Andrew C. Adams	129
8	Serum FGF21 levels are associated with brown adipose tissue activity in humans 2015 ·Scientific Reports ·Mark J. W. Hanssen,Evie P. M. Broeders,Ricardo J. Samms,Maarten J. Vosselman,Anouk A.J.J. van der Lans,Christine C. Cheng,Andrew C. Adams,Wouter D. van Marken Lichtenbelt,Patrick Schrauwen	113
9	Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice 2015 ·PLoS ONE ·Daniel A. Briere,Xiaoping Ruan,Christine C. Cheng,Angela M. Siesky,Thomas Fitch,(unknown),(unknown),Carlos Closa,Chen S. Suen,Yanping Xu,Tamer Coşkun,M. Dodson Michael	66
10	Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR) 2014 ·Toxicology and Applied Pharmacology ·Xingguo Cheng,(unknown),Jie Liu,Christine C. Cheng,Alexei Kharitonenkov,Curtis D. Klaassen	33
11	Interplay between FGF21 and insulin action in the liver regulates metabolism 2014 ·Journal of Clinical Investigation ·Brice Emanuelli,Sara G. Vienberg,Graham Smyth,Christine C. Cheng,Kristin I. Stanford,Manimozhiyan Arumugam,(unknown),Andrew C. Adams,Alexei Kharitonenkov,C. Ronald Kahn	194
12	Glucocorticoid Receptor Modulators Informed by Crystallography Lead to a New Rationale for Receptor Selectivity, Function, and Implications for Structure-Based Design 2014 ·Journal of Medicinal Chemistry ·Matthew W. Carson,J.G. Luz,Chen S. Suen,Chahrzad Montrose,Richard W. Zink,Xiaoping Ruan,Christine C. Cheng,Harlan W. Cole,Mary D. Adrian,(unknown),Thomas E. Mabry,Nancy Snyder,(unknown),(unknown),David K. Clawson,Anna Pustilnik,Michael J. Coghlan	25
13	Novel Sandwich Immunoassays for The Measurement of Total and Active Fgf21 2014 ·Bioanalysis ·(unknown),John H. Sloan,Jinbiao Chen,Christine C. Cheng,Robert W. Siegel,Yuewei Qian,Jason S. Troutt,Robert J. Konrad	13
14	Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones 2013 ·Molecular Metabolism ·Andrew C. Adams,Tamer Coşkun,Christine C. Cheng,Libbey S. O′Farrell,Susan L. DuBois,Alexei Kharitonenkov	68
15	Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319 2013 ·PLoS ONE ·Alexei Kharitonenkov,John M. Beals,Radmila Micanovic,Beth A. Strifler,(unknown),Victor J. Wroblewski,Shun Li,Anja Köester,Amy Ford,Tamer Coşkun,James D. Dunbar,Christine C. Cheng,Christopher C. Frye,Thomas F. Bumol,David E. Moller	146
16	An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Micebreakdown → 2013 ·Cell Metabolism ·William L. Holland,Andrew C. Adams,Joseph T. Brozinick,Hai H. Bui,(unknown),Christine M. Kusminski,Steven M. Bauer,Mark Wade,Esha Singhal,Christine C. Cheng,Katherine T. Volk,(unknown),Ruth Gordillo,Alexei Kharitonenkov,Philipp E. Scherer	455
17	FGF21 Requires βklotho to Act In Vivo 2012 ·PLoS ONE ·Andrew C. Adams,Christine C. Cheng,Tamer Coşkun,Alexei Kharitonenkov	154
18	The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue 2012 ·Molecular Metabolism ·Andrew C. Adams,Chaofeng Yang,Tamer Coşkun,Christine C. Cheng,Ruth E. Gimeno,Yongde Luo,Alexei Kharitonenkov	234
19	Plasma FGF21 Is Elevated by the Intense Lipid Mobilization of Lactation 2011 ·Endocrinology ·K.M. Schoenberg,Sarah L. Giesy,K.J. Harvatine,M.R. Waldron,Christine C. Cheng,Alexei Kharitonenkov,Yves R. Boisclair	73
20	The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand 2004 ·Molecular Pharmacology ·Thomas P. Burris,Chahrzad Montrose,Keith A. Houck,Harold E. Osborne,Wayne P. Bocchinfuso,Benjamin C. Yaden,Christine C. Cheng,Richard W. Zink,Robert J. Barr,(unknown),Venkatesh Krishnan,Heather A. Bullock,(unknown),Rachelle J. Sells Galvin,Kelli Bramlett,Keith R. Stayrook	113

About Christine C. Cheng

Christine C. Cheng is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Cancer Research, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (16 papers), Kruppel-like factors research (12 papers) and Epigenetics and DNA Methylation (11 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Physiology (516 citations) and Endocrine and Autonomic Systems (90 citations). Christine C. Cheng has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Alexei Kharitonenkov, Andrew C. Adams, Tamer Coşkun, Ruth E. Gimeno, Ricardo J. Samms, Yongde Luo, Chaofeng Yang, Christine M. Kusminski, William L. Holland and Katherine T. Volk. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact